Epidemiology

You have full text access to this OnlineOpen article

ATM sequence variants associate with susceptibility to non-small cell lung cancer

  1. Hushan Yang1,
  2. Margaret R. Spitz1,
  3. David J. Stewart2,
  4. Charles Lu2,
  5. Ivan P. Gorlov1,
  6. Xifeng Wu1,†,*

Article first published online: 20 JUN 2007

DOI: 10.1002/ijc.22918

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 10, pages 2254–2259, 15 November 2007

Additional Information

How to Cite

Yang, H., Spitz, M. R., Stewart, D. J., Lu, C., Gorlov, I. P. and Wu, X. (2007), ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int. J. Cancer, 121: 2254–2259. doi: 10.1002/ijc.22918

Author Information

  1. 1

    Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

  2. 2

    Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

  1. †

    Fax: +713-792-4657.

*Department of Epidemiology, Box 1340, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 20 JUN 2007
  3. Manuscript Accepted: 18 APR 2007
  4. Manuscript Received: 15 AUG 2006

Funded by

  • NCI. Grant Numbers: CA 111646, CA 55769, CA 70907, DAMD17-02-1-0706
  • Flight Attendant Medical Research Institute

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (97K)

References

  • 1
    Breuer RH, Postmus PE, Smit EF. Molecular pathology of non-small-cell lung cancer. Respiration 2005; 72: 313–30.
  • 2
    Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 2005; 65: 349–57.
  • 3
    Zhao H, Spitz MR, Tomlinson GE, Zhang H, Minna JD, Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res 2001; 61: 7819–24.
  • 4
    Taylor AM, Byrd PJ. Molecular pathology of ataxia telangiectasia. J Clin Pathol 2005; 58: 1009–15.
  • 5
    Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155–68.
  • 6
    Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421: 499–506.
  • 7
    Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005; 308: 551–4.
  • 8
    Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 2003; 63: 3325–33.
  • 9
    Fan R, Kumaravel TS, Jalali F, Marrano P, Squire JA, Bristow RG. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression. Cancer Res 2004; 64: 8526–33.
  • 10
    Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 2005; 97: 813–22.
  • 11
    Zhang L, Jia G, Li WM, Guo RF, Cui JT, Yang L, Lu YY. Alteration of the ATM gene occurs in gastric cancer cell lines and primary tumors associated with cellular response to DNA damage. Mutat Res 2004; 557: 41–51.
  • 12
    Jones JS, Gu X, Lynch PM, Rodriguez-Bigas M, Amos CI, Frazier ML. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control 2005; 16: 749–53.
  • 13
    Monni O, Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 2001; 40: 259–66.
  • 14
    Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol 2006; 26: 4339–50.
  • 15
    Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 821–5.
  • 16
    Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003; 63: 8717–25.
  • 17
    Tamimi RM, Hankinson SE, Spiegelman D, Kraft P, Colditz GA, Hunter DJ. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study. Breast Cancer Res 2004; 6: R416–R22.
  • 18
    Gutierrez-Enriquez S, Fernet M, Dork T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angele S, Hall J. Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes Chromosomes Cancer 2004; 40: 109–19.
    Direct Link:
  • 19
    Maillet P, Chappuis PO, Vaudan G, Dobbie Z, Muller H, Hutter P, Sappino AP. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer 2000; 88: 928–31.
    Direct Link:
  • 20
    Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Nieminen P, Winqvist R. Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer 2005; 116: 69–72.
    Direct Link:
  • 21
    Koren M, Kimmel G, Ben-Asher E, Gal I, Papa MZ, Beckmann JS, Lancet D, Shamir R, Friedman E. ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 2006; 94: 1537–43.
  • 22
    Kim JH, Kim H, Lee KY, Choe KH, Ryu JS, Yoon HI, Sung SW, Yoo KY, Hong YC. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006; 15: 1181–6.
  • 23
    Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer 2006; 119: 724–5.
    Direct Link:
  • 24
    Bonnen PE, Story MD, Ashorn CL, Buchholz TA, Weil MM, Nelson DL. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am J Hum Genet 2000; 67: 1437–51.
  • 25
    Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 2005; 11: 1408–15.
  • 26
    Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ, Wu X. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 2003; 95: 540–7.
  • 27
    Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162–9.
  • 28
    Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65: 11771–8.
  • 29
    Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000; 35: 206–21.
    Direct Link:
  • 30
    Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 2004; 3: 889–900.
  • 31
    Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281: 1674–7.
  • 32
    Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281: 1677–9.
  • 33
    Knudson A. Alfred Knudson and his two-hit hypothesis. (Interview by Ezzie Hutchinson). Lancet Oncol 2001; 2: 642–5.
View Full Article (HTML) Get PDF (97K)